North Star Investment Management Decreased Psychemedics Com New (PMD) Position By $965,352, 4 Analysts Covering Guyana Goldfields Inc. (TSE:GUY)

May 19, 2017 - By Kurt Siggers

North Star Investment Management Corp decreased Psychemedics Corp Com New (PMD) stake by 35.85% reported in 2016Q4 SEC filing. North Star Investment Management Corp sold 40,223 shares as Psychemedics Corp Com New (PMD)’s stock 0.00%. The North Star Investment Management Corp holds 71,979 shares with $1.78M value, down from 112,202 last quarter. Psychemedics Corp Com New now has $109.40M valuation. The stock increased 1.78% or $0.37 on May 18, reaching $21.1. About shares traded. Psychemedics Corp. (NASDAQ:PMD) has risen 6.00% since April 19, 2017 and is uptrending. It has by 0.00% the S&P500.

Among 4 analysts covering Guyana Goldfields Inc. (TSE:GUY), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Guyana Goldfields Inc. had 23 analyst reports since September 1, 2015 according to SRatingsIntel. As per Wednesday, April 12, the company rating was maintained by Scotia Capital. Scotia Capital maintained Guyana Goldfields Inc. (TSE:GUY) rating on Friday, February 3. Scotia Capital has “Outperform” rating and $9 target. The rating was maintained by RBC Capital Markets with “Outperform” on Thursday, November 17. The firm has “Focus Stock” rating by Scotia Capital given on Thursday, December 22. RBC Capital Markets maintained it with “Outperform” rating and $5 target in Tuesday, January 19 report. The company was upgraded on Tuesday, January 19 by BMO Capital Markets. Scotia Capital maintained Guyana Goldfields Inc. (TSE:GUY) rating on Friday, February 24. Scotia Capital has “Outperform” rating and $9 target. The firm has “” rating by TD Securities given on Wednesday, November 25. See Guyana Goldfields Inc. (TSE:GUY) latest ratings:

12/04/2017 Broker: Scotia Capital Rating: Outperform New Target: $9.00 Maintain
24/02/2017 Broker: Scotia Capital Rating: Outperform New Target: $9.00 Maintain
03/02/2017 Broker: RBC Capital Markets Rating: Outperform Old Target: $8.00 New Target: $8.50 Target Up
03/02/2017 Broker: Scotia Capital Rating: Outperform New Target: $9.00 Maintain
10/01/2017 Broker: Scotia Capital Rating: Focus Stock New Target: $11.00 Target Up
22/12/2016 Broker: Scotia Capital Rating: Focus Stock New Target: $11.00 Maintain

Investors sentiment increased to 1.33 in 2016 Q4. Its up 0.05, from 1.28 in 2016Q3. It is positive, as 4 investors sold PMD shares while 14 reduced holdings. 10 funds opened positions while 14 raised stakes. 2.64 million shares or 1.26% more from 2.61 million shares in 2016Q3 were reported. 1,474 were accumulated by Prelude Capital Mgmt Ltd Llc. Morgan Stanley has invested 0% in Psychemedics Corp. (NASDAQ:PMD). National Planning accumulated 25,728 shares. Blackrock Institutional Tru Communications Na invested in 12,134 shares or 0% of the stock. Royal Bankshares Of Canada accumulated 0% or 170 shares. Connors Investor Services reported 0.05% in Psychemedics Corp. (NASDAQ:PMD). 52,078 are held by Acadian Asset Mngmt. Gsa Cap Limited Liability Partnership invested 0.01% of its portfolio in Psychemedics Corp. (NASDAQ:PMD). Vanguard reported 210,917 shares or 0% of all its holdings. Millennium Management Limited Liability Co holds 0% or 10,433 shares. Janney Montgomery Scott Ltd Liability Corporation has 12,918 shares for 0% of their portfolio. Deutsche Retail Bank Ag reported 34,362 shares stake. Bridgeway Cap Mngmt Inc stated it has 0% of its portfolio in Psychemedics Corp. (NASDAQ:PMD). Blackrock Fund has 0% invested in Psychemedics Corp. (NASDAQ:PMD). Mufg Americas Holding invested 0% in Psychemedics Corp. (NASDAQ:PMD).

Analysts await Psychemedics Corp. (NASDAQ:PMD) to report earnings on July, 25.

Since November 21, 2016, it had 0 insider buys, and 4 selling transactions for $506,146 activity. $216,147 worth of Psychemedics Corp. (NASDAQ:PMD) was sold by Dyke James V. on Thursday, March 9. 3,000 Psychemedics Corp. (NASDAQ:PMD) shares with value of $61,290 were sold by SCHAFFER MICHAEL I. Shares for $112,504 were sold by WEINERT FRED J on Monday, November 21.

North Star Investment Management Corp increased Abbvie Inc Com (NYSE:ABBV) stake by 6,107 shares to 59,035 valued at $3.70M in 2016Q4. It also upped First Tr Enhanced Eqty Inc Fd Com (NYSE:FFA) stake by 31,102 shares and now owns 317,041 shares. Coca Cola Co Com (NYSE:KO) was raised too.